Uptake of human papillomavirus vaccine among private and public female secondary school students in Asaba, Delta State, Nigeria: a comparative cross-sectional study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262073Keywords:
Human papillomavirus, HPV vaccine, Cervical cancer, Knowledge, UptakeAbstract
Background: Despite its availability, awareness and uptake of the human papillomavirus (HPV) vaccine have remained poor globally, especially in low and middle-income countries. The aim was to determine and compare the knowledge, attitude and uptake of HPV vaccine among private and public female secondary school students in Asaba, Delta State.
Methods: A comparative cross-sectional study of girls aged 10 and 18 years in public and private secondary schools in Asaba, Delta State. Interviewer-administered questionnaires were distributed to 200 eligible students after obtaining their assent and consent from their parents. The collected data were coded and analysed using SPSS version 26, and p<0.05 was considered significant.
Results: Only 24% (14% in private and 10% in public secondary schools), 14% (5% in private, 9% in public secondary schools) and 16% (6% in private, 10% in public secondary schools) of the respondents have heard of cervical cancer, HPV and HPV vaccine, respectively. There was a statistically significant association between school type and knowledge level (p=0.048). None of the respondents had received the HPV vaccine, with a lack of awareness being the reason for non-uptake in the majority of the respondents.
Conclusions: This study demonstrated poor knowledge of HPV/cervical cancer and a poor uptake of the HPV vaccine among respondents. Health education programs geared toward creating awareness among secondary school students and their parents in Delta State and other Nigerian states are highly recommended. Also, the government should make frantic efforts to sustain the HPV vaccine in the National Immunisation schedule.
References
Onwusulu DN, Ilikannu SO, Ochuba CO, Idama V, Egboduku E, Fagbemi AJ, et al. Age and pattern of cervical smear cytology in Federal Medical Centre Asaba – a five year review. Adv Med Pharm Dent Res J. 2025;5(1):33-7.
Ubajaka C, Ukegbu A, Ilikannu S, Ibeh C, Onyeonoro U, Ezeanyim A. Knowledge of cervical cancer and practice of pap smear testing among secondary school teachers in Nnewi North Local Government Area of Anambra State, South Eastern Nigeria. Adv Sex Med. 2015;5(2):13-21.
Ilikannu SO, Uzoka CP, Oyewumi ZO, Jombo SE, Okoye NP, Maduka NR, et al. Awareness and uptake of cervical cancer screening services among female nurses in a low-resource setting: A cross-sectional study. Int J Reprod Contracept Obstet Gynaecol. 2026;15(2):490-7.
Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-203.
World Health Organization. WHO updates recommendations on HPV vaccination schedule. 2022. Available at: https://www.who.int/news /item/20-12-2022WHO-updates-recommendations-on-HPV-vaccination-schedule. Accessed on 09 March 2026.
Garcia LM, Holschneider CH. Premalignant and malignant disorders of the uterine cervix. In: Decherney AH, Nathan L, Laufer N, Roman AS, editors. Curr Diagn Treat Obstet Gynaecol. 2019;12:837-62.
Oluwole EO, Idowu OM, Adejimi AA, Balogun MR, Osanyin GE. Knowledge, attitude and uptake of human papillomavirus vaccination among female undergraduates in Lagos State, Nigeria. J Family Med Prim Care. 2019;8(11):3627-33.
Fehintola OF, Fehintola OA, Ogundele AO, Adegbenro AC, Olowooker AS, Afolabi TO. Predictors and acceptability of human papilloma virus vaccine uptake among senior secondary school students in Ile-Ife. Sanamed. 2019;14(4):153-61.
Ojimah C, Maduka O. Awareness and uptake of human papillomavirus vaccines among female undergraduates: implications for cervical cancer prevention in south-south Nigeria. Port Harcourt Med J. 2017;11:134-40.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49.
Biyazin T, Yilma A, Yetwale A, Fenta B, Dagnaw Y. Knowledge and attitude about human papillomavirus vaccine among female high school students at Jimma town, Ethiopia. Hum Vaccin Immunother. 2022;18(1):2036522.
Isara AR, Osayi N. Knowledge of human papillomavirus and uptake of its vaccine among female undergraduate students of Ambrose Alli University, Ekpoma, Nigeria. J Community Med Prim Health Care. 2021;33(1):64-75.
Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789-99.
World Health Organisation. Cervical cancer. 2025. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed on 09 March 2026.
Bolarinwa OA. Sample size estimation for health and social science researchers: the principles and considerations for different study designs. Niger Postgrad Med J. 2020;27:67-75.
Ojeleye OA, Adejumo PO. Knowledge and Acceptance of HPV Vaccination among Lagos Students. Afr J Midwifery Women’s Health. 2019;13(2):1-9.
Varkey B. Principles of Clinical Ethics and Their Application to Practice. Med Princ Pract. 2021;30(1):17-28.
Ezeanochie M, Olasimbo P. Awareness and uptake of human papilloma virus vaccines among female secondary school students in Benin City, Nigeria. Afr Health Sci. 2020;20(1):45-50.
Ifediora CO, Azuike EC. Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria. Trop Med Int Health. 2018;23(7):714-23.
Ndikom CM, Oboh PI. Perception, acceptance and uptake of human papillomavirus vaccine among female adolescents in selected secondary schools in Ibadan, Nigeria. Afr J Biomed Res. 2017;20:237-44.
Jalani MFF, Rani MM, Isahak I, Mohd Aris MS, Roslan N. Knowledge, attitude and practice of human papillomavirus (HPV) vaccination among secondary school students in rural areas of Negeri Sembilan, Malaysia. Int J Collab Res Intern Med Public Health. 2016;8(6):420-34.
Kristina SU, Permitasare NAL. Knowledge, attitude and barriers towards human papillomavirus (HPV) vaccination in developing economies of the South-East Asia Region: A systematic review. Syst Rev Pharm. 2019;10(2):81-6.
Nhumba N, Sunguya B. Low uptake of the second dose of human papillomavirus vaccine in Dar es Salaam, Tanzania. Vaccines. 2022;10(11):1919.
Nabirye J, Okwi LA, Nuwematsiko R, Kiwanuka G, Muneza F, Kamya C, et al. Health system factors influencing uptake of human papilloma virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda. BMC Public Health. 2020;20(1):171.
Perlman S, Wamai RG, Bain PA, Welty T, Welty E. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in Sub-Saharan Africa: A systematic review. PLoS One. 2014;9(3):e90912.
Guodong L, Lan K, Ping D. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US. Papillomavirus Res. 2016;2:1-8.